disufenton sodium has been researched along with Brain Emboli in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lapchak, PA; Song, D; Wei, J; Zivin, JA | 1 |
| Savitz, SI | 1 |
| Araujo, DM; Lapchak, PA; Song, D; Wei, J; Zivin, JA | 1 |
| Araujo, DM; Lapchak, PA; Purdy, R; Song, D; Wei, J; Zivin, JA | 1 |
1 review(s) available for disufenton sodium and Brain Emboli
| Article | Year |
|---|---|
A critical appraisal of the NXY-059 neuroprotection studies for acute stroke: a need for more rigorous testing of neuroprotective agents in animal models of stroke.
Topics: Animals; Benzenesulfonates; Cerebral Infarction; Clinical Trials as Topic; Disease Models, Animal; Drug Evaluation, Preclinical; Humans; Intracranial Embolism; Neuroprotective Agents; Reproducibility of Results; Research Design; Stroke | 2007 |
3 other study(ies) available for disufenton sodium and Brain Emboli
| Article | Year |
|---|---|
Coadministration of NXY-059 and tenecteplase six hours following embolic strokes in rabbits improves clinical rating scores.
Topics: Animals; Behavior, Animal; Benzenesulfonates; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Fibrinolytic Agents; Free Radical Scavengers; Intracranial Embolism; Male; Neuroprotective Agents; Nitrogen Oxides; Rabbits; Severity of Illness Index; Stroke; Tenecteplase; Time Factors; Tissue Plasminogen Activator | 2004 |
Neuroprotective effects of the spin trap agent disodium-[(tert-butylimino)methyl]benzene-1,3-disulfonate N-oxide (generic NXY-059) in a rabbit small clot embolic stroke model: combination studies with the thrombolytic tissue plasminogen activator.
Topics: Animals; Behavior, Animal; Benzenesulfonates; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Therapy, Combination; Fibrinolytic Agents; Intracranial Embolism; Male; Microspheres; Neuroprotective Agents; Nitrogen Oxides; Rabbits; Spin Trapping; Stroke; Time Factors; Tissue Plasminogen Activator; Treatment Outcome | 2002 |
Effects of the spin trap agent disodium- [tert-butylimino)methyl]benzene-1,3-disulfonate N-oxide (generic NXY-059) on intracerebral hemorrhage in a rabbit Large clot embolic stroke model: combination studies with tissue plasminogen activator.
Topics: Animals; Benzenesulfonates; Blood Glucose; Body Temperature; Cerebral Hemorrhage; Disease Models, Animal; Drug Therapy, Combination; Fibrinolytic Agents; Intracranial Embolism; Male; Neuroprotective Agents; Nitrogen Oxides; Rabbits; Stroke; Tissue Plasminogen Activator; Treatment Outcome | 2002 |